Clinical Trials Directory

Trials / Completed

CompletedNCT00392613

RAte Control Efficacy in Permanent Atrial Fibrillation

RAte Control Efficacy in Permanent Atrial Fibrillation, a Comparison Between Lenient Versus Strict Rate Control in Patients With and Without Heart Failure.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
500 (estimated)
Sponsor
University Medical Center Groningen · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The investigators hypothesis is that in patients with permanent AF lenient rate control is not inferior to strict rate control in terms of cardiovascular mortality, morbidity, neurohormonal activation, NYHA class for heart failure, left ventricular function, left atrial size, quality of life and costs. Lenient rate control is defined as a resting heart rate \<110 bpm.Strict rate control is defined as a mean resting heart rate \< 80 beats per minute (bpm) and heart rate during minor exercise \< 110 bpm. Patients will be seen after 1, 2, 3 months (for titration of rate control drugs) and thereafter yearly.

Detailed description

Study objectives: 1. To show that lenient rate control is not inferior to strict rate control in terms of cardiovascular mortality and morbidity 2. To show that lenient rate control is not inferior to strict rate control in terms of all cause mortality, cardiovascular hospitalizations, NYHA class for exercise tolerance, left ventricular function and left atrial size, quality of life, neurohormonal activation as measured by NT-proBNP, hospitalization for heart failure, syncope, sustained ventricular tachycardia, appropriate shocks or anti-tachycardia pacing of ICD for ventricular arrhythmias, cardiac arrest, and pacemaker implantations, stroke, systemic emboli, and bleeding, unstable angina pectoris and myocardial infarction, costs and renal function

Conditions

Interventions

TypeNameDescription
PROCEDUREStrict versus lenient rate control

Timeline

Start date
2005-01-01
Primary completion
2009-12-01
First posted
2006-10-26
Last updated
2010-01-07

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00392613. Inclusion in this directory is not an endorsement.